• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

ZEPOSIA® (ozanimod), a Sphingosine 1-Phosphate Receptor Modulator for Relapsing Forms of Multiple Sclerosis

home / publications / supplement / zeposia-ozanimod-a-sphingosine-1-phosphate-receptor-modulator-for-relapsing-forms-of-multiple-sc
© 2024 MJH Life Sciences
AJMC®
All rights reserved.